Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
A prospective, randomized comparison of bupivacaine to liposomal bupivacaine given by local
injection at all the wound sites in patients undergoing robotic-assisted or laparoscopic
urologic surgeries in an effort to determine which method reduced postoperative opioid use
the most.